Stromal Myofibroblasts Accompany Modifications in the Epithelial Phenotype of Tongue Dysplastic and Malignant Lesions
Tóm tắt
Stromal myofibroblasts (SMF) associated with various types of carcinomas are believed to emerge under the influence of the tumor cells. Recent studies have shown that SMF may originate from fibroblasts within the tumor stroma or even from carcinoma cells by the process of epithelial-mesenchymal transition. The aim of this study was to investigate the concomitant expression of epithelial membrane antigen and α-smooth muscle actin in cells at the tumor-connective tissue interface in human tongue carcinoma, as a possible reflection of epithelial-mesenchymal transition. Given its key role in this process, expression of transforming growth factor-β in the malignant cells was assessed as well. Immunostaining with α-smooth muscle actin was performed on cases of hyperplasia (n = 16), mild dysplasia (n = 12), moderate-to-severe dysplasia (n = 11) and carcinoma (n = 22). Transforming growth factor-β assessment and double immunostaining with epithelial membrane antigen and α-smooth muscle actin were performed only in cases of carcinoma. SMF were significantly associated with carcinomas, while their number in pre-malignant lesions (hyperplasia and dysplasia) was significantly lower (P < 0.001). Although SMF were found in all carcinomas, they were heterogeneous in their frequency and patterns of distribution. In addition, 95% of the carcinomas expressed transforming growth factor-β and 41% exhibited cells positive for both epithelial membrane antigen and α-smooth muscle actin. SMF were almost exclusively associated with established carcinomas and not with pre-malignant lesions. Cells that co-expressed epithelial membrane antigen and α-smooth muscle actin can be a manifestation of epithelial-mesenchymal transition and, as such, may serve as a source for SMF in these tumors. These findings appear to be linked to the frequent expression of transforming growth factor-β by the malignant cells.
Tài liệu tham khảo
Kademani D (2007) Oral Cancer. Mayo Clin Proc 82(7):878–887 (erratum: Mayo Clin Proc 2007 82(8):1017)
Choi S, Myers JN (2008) Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87(1):14–32
Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6(5):392–401
Tlsty TD, Hein PW (2001) Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11(1):54–59
Elenbaas B, Weinberg RA (2001) Heterotopic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 264(1):169–184
Mueller MM, Fusening NE (2004) Friends or foes–bipolar effects of the tumor stroma in cancer. Nat Rev Cancer 4(11):839–849
Zeisberg EM, Potenta S, Xie L et al (2007) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67(21):10123–10128
Tomasek JJ, Gabbiani G, Hinz B et al (2002) Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 3(5):349–363
Lohr M, Schimdt C, Ringel J et al (2001) Transforming growth factor β-1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res 61(2):550–555
Aoyagi Y, Oda T, Kinoshita T et al (2004) Overexpression of TGF- β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cells. Br J Cancer 91(7):1316–1326
De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200(4):429–447
Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2):131–142
Nawshad A, LaGamba D, Polad A et al (2005) Transforming growth factor-β signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 179(1–2):11–23
Trelstad RL, Hay ED, Revel JD (1967) Cell contact during early morphogenesis in the chick embryo. Dev Biol 16(1):78–106
Yang J, Mani SA, Donaher JL et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7):927–939
Radisky DC, Kenny PA, Bissell MJ (2007) Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem 101(4):830–839
Takkunen M, Grenman R, Hakkunen M et al (2006) Snail-dependent and–independent epithelial-mesenchymal transition in oral squamous carcinoma cells. J Histochem Cytochem 54(11):1263–1275
Yokoyama K, Kamata N, Hayashi E et al (2001) Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma in vitro. Oral Oncol 37(1):65–71
Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J et al (2006) Reduced E-cadherin is an indicator of unfavorable prognosis in oral squamous cell carcinoma. Oral Oncol 42(2):190–200
Vered M, Allon I, Buchner A et al (2007) Stromal myofibroblasts and malignant transformation in a 4NQO rat tongue carcinogenesis model. Oral Oncol 43(10):999–1006
Vered M, Polak-Charcon S, Babushkin T et al (2008) 4NQO-induced tongue carcinoma: an ultrastructural study. Ultrastruct Pathol 32(5):199–205
Gale N, Pilch BZ, Sidransky D et al (2005) Epithelial precursor lesions. In: Barnes L, Eveson JW, Reichart P et al (eds) WHO classification of tumours. Pathology and genetics. Head and neck tumours. IARC, Lyon, pp 177–179
Pinkus GS, Kurtin PJ (1985) Epithelial membrane antigen–a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol 16(9):929–940
Logullo AF, Nonogaki S, Miguel RE et al (2003) Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis. J Oral Pathol Med 32(3):139–145
Lewis MP, Lygoe KA, Nystrom ML et al (2004) Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 90(4):822–832
Barth PJ, Schenck zu Schweinsberg T, Ramaswamy A et al (2004) CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch 444(3):231–234
Vered M, Shohat I, Buchner A et al (2005) Myofibroblasts in stroma of odontogenic cysts and tumors can contribute to variations in the biological behavior of lesions. Oral Oncol 41(10):1028–1033
Kellermann MG, Sobral LM, da Silva SD et al (2007) Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 51(6):849–852
Lynch CC, Matrisian LM (2002) Matrix metalloproteinases in tumor-host cell communication. Differentiation 70(9–10):561–573
Patel PB, Shah PM, Rawal UM et al (2005) Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 90(2):81–88
de Vicente GJ, Fresno MF, Villalain L et al (2005) Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41(3):283–293
Prime SS, Davies M, Pring M et al (2004) The role of TGF-β I epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II). Crit Rev Oral Biol Med 15(6):337–347
Maeda G, Chiba T, Okazaki M et al (2005) Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression. Int J Oncol 27(6):1535–1541
Pyo SW, Hashimoto M, Kim YS et al (2007) Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg 35(1):1–9
Lim SC, Zhang S, Ishii G et al (2004) Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 10(1 Pt 1):166–172
Huang Y, Fernandez SV, Goodwin S et al (2007) Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res 67(23):11147–11157
Guarino M (2007) Epithelial-mesenchymal transition and tumor invasion. Int J Biochem Cell Biol 39(12):2153–2160